Table Of Contents
1. Introduction 22
1.1. Objectives Of The Study 22
1.2. Market Definition 22
1.3. Overview Of North America Hernia Mesh Repair Devices Market 22
1.4. Currency And Pricing 23
1.5. Limitation 23
1.6. Markets Covered 23
2. Market Segmentation 26
2.1. Markets Covered 26
2.2. Geographic Scope 27
2.3. Years Considered For The Study 28
2.4. Currency And Pricing 28
2.5. Research Methodology 29
2.6. Primary Interviews With Key Opinion Leaders 32
2.7. Secondary Sources 33
2.8. Assumptions 33
3. Market Overview 34
3.1. Drivers 36
3.1.1. Increasing Number Of Hernia Surgeries 36
3.1.2. Increasing Prevalence Of Hernia Diseases 36
3.1.3. Increasing Demand For Advanced Meshes 37
3.1.4. Technological Advancements 37
3.2. Restraints 38
3.2.1. High Cost Of Hernia Surgery 38
3.2.2. Problems Related With Hernia Mesh Repair Surgery 38
?
3.3. Opportunities 38
3.3.1. Collaborations With The Robotic Surgery Devices Manufacturers 38
3.4. Challenges 39
3.4.1. Inconsistent Reimbursement Policies 39
4. Premium Insights 40
5. Executive Summary 42
6. North America Hernia Mesh Repair Devices Market, By Product Type 44
6.1. Overview 45
6.2. Synthetic Mesh 47
6.2.1. 3D Mesh 49
6.2.2. Flat Mesh 49
6.2.3. Synthetic Hernia Mesh, By Structure 49
6.2.3.1. Absorbable Mesh 49
6.2.3.2. Non-Absorbable Mesh 49
6.3. Biological Type 50
7. North America Hernia Mesh Repair Devices Market, By Hernia Type 51
7.1. Overview 52
7.2. North America Hernia Mesh Repair Devices Market, By Hernia Type 53
7.3. Inguinal Hernia 54
7.4. Incisional Hernia 55
7.5. Umbilical Hernia 56
7.6. Femoral Hernia 57
7.7. Hiatal Hernia 58
7.8. Parastomal Hernia 59
7.9. Others 60
?
8. North America Hernia Mesh Repair Market, By Geography 61
8.1. Overview 62
8.2. North America 69
8.2.1. U.S. 77
8.2.2. Canada 79
8.2.3. Mexico 81
9. North America Hernia Mesh Repair Devices Market,
Company Landscape 179
9.2. Company Share Analysis; North America 180
10. Company Profiles 183
10.1. Johnson & Johnson Services, Inc 183
10.1.1. Company Overview 183
10.1.2. Johnson & Johnson Services, Inc; Revenue Analysis 184
10.1.3. Product Portfolio 185
10.1.4. Recent Developments 186
10.2. Medtronic 187
10.2.1. Company Overview 187
10.2.2. Medtronic; Revenue Analysis 188
10.2.3. Product Portfolio 189
10.2.4. Recent Developments 190
10.3. C. R. Bard, Inc. 191
10.3.1. Company Overview 191
10.3.2. C. R. Bard, Inc.; Revenue Analysis 192
10.3.3. Product Portfolio 193
10.3.4. Recent Developments 193
10.4. W. L. Gore & Associates, Inc. 194
10.4.1. Company Overview 194
10.4.2. W. L. Gore & Associates, Inc. ; Company Snapshot 194
10.4.3. Product Portfolio 195
10.4.4. Recent Developments 195
10.5. Integra Lifesciences Corporation 196
10.5.1. Integra Lifesciences Corporation.; Revenue Analysis 196
10.5.2. Product Portfolio 197
10.5.3. Recent Developments 197
10.6. B. Braun Melsungen Ag 198
10.6.1. Company Overview 198
10.6.2. B. Braun Melsungen Ag; Revenue Analysis 198
10.6.3. Product Portfolio 199
10.6.4. Recent Developments 199
10.7. Atrium 200
10.7.1. Company Overview 200
10.7.2. Atrium; Revenue Analysis 200
10.7.3. Product Portfolio 201
10.7.4. Recent Developments 202
10.8. Acelity L.P. Inc 203
10.8.1. Company Overview 203
10.8.2. Acelity L.P. Inc ;Revenue Analysis 203
10.8.3. Product Portfolio 204
10.8.4. Recent Developments 204
10.9. Zimmer Biomet 205
10.9.1. Company Overview 205
10.9.2. Zimmer Biomet ; Company Snapshot 205
10.9.3. Product Portfolio 206
10.9.4. Recent Developments 206
10.10. Baxter International Inc. 207
10.10.1. Company Overview 207
10.10.2. Baxter International Inc. ;Revenue Analysis 208
10.10.3. Product Portfolio 208
10.10.4. Recent Developments 208
11. Related Reports 209